MUC16 and ovarian carcinoma: When distinguishing benign ovarian tumor from early stage ovarian cancer, Nolen et al. reported improved sensitivity and specificity of 74.2% and 85%, respectively, when CA125 and HE4 tests were used as a dual test [33].